Supriya Lifescience has received Good Manufacturing Practice (GMP) certification from the Regulatory Authority of Brazil, ANVISA for its manufacturing site in Lote Parshuram. This success in the rigorous GMP inspection underscores Supriya’s commitment to the highest quality standards and the excellence of its smart manufacturing practices.
The clearance of this audit marks the successful registration of 8 APIs with CADIFA and will further enable smoother and faster registration of the company’s other APIs. This Successful Inspection paves the way for Supriya Lifescience to acquire more customers in the Brazilian Pharmaceutical market.
Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: